Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non-cash Items (2024 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Non-cash Items for 2 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 27.25% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 27.25% year-over-year, with the annual reading at $5.6 million for FY2025, 27.25% up from the prior year.
  • Non-cash Items hit $5.6 million in Q4 2025 for Harmony Biosciences Holdings, up from $5.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $29.8 million in Q2 2025 to a low of $4.3 million in Q3 2024.